Prev：Selective degradation of tRNASer(AGY) is the primary driver for mitochondrial seryl-tRNA synthetase-related disease(KTB1850-19.16)
Next：Salivary non-apoptotic tumoral microvesicles: A potential progressive marker in oral cancer patients(A23620-5.295)
